Robert S. Brown Jr., MD, MPH

Transplant Hepatology (Board Certified, Primary Specialty)
Gastroenterology (Board Certified)
Internal Medicine (Board Certified)
Cancer Care
Office Phone: (646) 962-5483
One of America's Top Doctors
Rated one of New York Magazine's Best Doctors

Biography

Robert S. Brown, Jr., MD, MPH is the Director of the Center for Liver Disease and Transplantation at New York-Presbyterian Hospital in New York. Dr. Brown is Vice Chair of Transitions of Care and Interim Chief of the Division of Gastroenterology and Hepatology in the Department of Medicine Weill Cornell Medical College in New York, New York. He is also Professor of Clinical Medicine at Columbia University College of Physicians & Surgeons.

Dr. Brown received his bachelor degree from Harvard College, his medical degree from New York University and his Master of Public Health from the Graduate School of Public Health, University of California in Berkeley. Following the completion of his medical degree,he fulfilled his internship in Medicine at Beth Israel Hospital in Boston and his fellowship in gastroenterology and hepatology at the University of California in San Francisco.

Dr. Brown is an internationally known expert in liver disease and liver transplantation. He has co-authored over 150 peer-reviewed articles most dedicated to viral hepatitis and liver transplantation and has extensive research funding in those areas. He is an Associate Editor for Liver Transplantation and Gastroenterology and Hepatology News and published a book, "Common Liver Diseases and Transplantation: An Algorithmic Approach to Work-up and Management". He was awarded the Young Investigator Award from the American Society of Transplant Physicians, the Senior Attending Teacher Award from Columbia University Medical Center, and the American Liver Foundation New York Chapter's Physician of the Year.

Area of Expertise

Please contact the doctor's office to verify that your insurance is accepted.

Aetna [HMO, PPO]

Affinity [Access (Exchange)]

Cigna

Emblem/HIP

Empire Blue Cross Blue Shield [Blue Priority, EPO, HMO, Pathway (Exchange), PPO]

Empire Blue Cross Blue Shield HealthPlus

Fidelis Care

GHI [CBP]

Healthfirst

Medicaid

Oxford Health Plans [Freedom, Liberty]

POMCO

UnitedHealthcare [Compass (Exchange), EPO, HMO, POS, PPO]

VNSNY CHOICE

Education

New York University School of Medicine

MD, 1989 New York University School of Medicine

MPH, 1996 University of California, Berkeley

Internship: Beth Israel Hospital, Boston, MA

Residency: Beth Israel Hospital, Boston, MA

Fellowship: University of California-San Francisco Medical Center

Publications

Abstracts

  • New Data from Largest U.S. Hepatitis C Trial Provide Insights Into Optimizing Treatment for Patient Populations Traditionally Considered Difficult to Treat

Peer-Reviewed Articles

  • Brown R, Jacobson I. Tenofovir Disoproxil Fumarate in Patients with Lamivudine-Resistant Chronic Hepatitis B Virus Infection: A Review. Am Jour of Gastoenterol (submitted)
  • Sher L, Jennings L, Rudich S, Netto G, Teperman L, Kinkhabwala M, Brown RS Jr., Pomfret E, Klintmalm G, HCV-3 Study Group. The Impact of Live Donor Liver Transplantation on Hepatitis C Recurrence: The HCV 3 Trial Experience. (In oress)
  • Liaw Y, Raptopoulou-Gigi M, Cheinquer H, Sarin SK, Tanwandee T, Leung N, Peng CY, Myers RP, Brown RS Jr., Jeffers L, Tsai N, Bialkowska J, Tang S, Beebe S, Cooney E. Efficacy and Safety of Entecavir versus Adefovir in Chronic Hepatitis B Patients with Hepatic Decompensation: A Randomized Open-Label Study (submitted)
  • Trotter JF, Gillespie BW, Terrault NA, Abecassis MM, Merion RM, Brown RS Jr, Olthoff KM, Hayashi PH, Berg CL, Fisher RA, Everhart JE, and the Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Laboratory Test Results After Living Liver Donation in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study. Liver Transpl 17:409-417, 2011
  • Hu K, Reilich B, Brown RS, Brass C, Seibel J, Macobson IM. Impact of Hispanic or Asian Ethnicity on the Treatment Outcomes of Chronic Hepatitis C. J. Clin Gastroenterol 2011 (in press)
  • Terrault NA, Tran TT, Schiff E, McGuire BM, Brown RS Jr., Tupper R., Ramanathan S, Enejosa J, Zhong L, Zong J – for the Study 531 Team. Pharmacokinetics of Tacrolimus Co-administered with Adefovir Dipivoxil to Liver Transplant Recipients (submitted)
  • Hassanein T, Blei AT, Perry W, Hilsabeck R, Stange J, Larsen FS, Brown RS Jr., Caldwell S, McGuire B, Nevens F, Fontana R. Performance of the Hepatic Encephalopathy Scoring Algorithm in a Clinical Trial of Patients with Cirrhosis and Severe Hepatic Encephalopathy. Am Jour of Gastroenterol (submitted)
  • Hoofnagle JH, Wahed AS, Brown RS Jr., Howell CD, Belle SH for the Virahep-C Study Group. Early Changes in Hepatitis C Viral Levels in Response to Peginterferon and Ribavirin in African American and Caucasian American Patients with Chronic hepatitis C, Genotype 1 Infection. (submitted)
  • Yu J, Neugut A, Wang S, Jacobson J, Ferrante L, Khungar V, Lim E, Hershman D, Brown R, Siegel A. Racial and Insurance Disparities in the Receipt of Transplant among Patients with Hepatocellular Carcinoma (in press)
  • Peng T, Zamanian R, Krowka M, Benza R, Roberts K, Taichman D, Rybak D, Trotter J, Brown RS, Fallon M, Kawut S. Plasma Levels of S100A4 in Portopulmonary Hypertension. BiOMARKERS (in press)
  • Roberts KE, Fallon MB, Krowka MJ, Benza RL, Knowles JA, Badesch DB, Brown RS Jr., Taichman DB, Trotter JF, Zachs S, Horn EM, Kawut SM for the PVCLD Study Group. Serotonin Transporter Polymorphisms in Patients with Portopulmonary Hypertension. Chest (in press)
  • Rybak D, Fallon MB, Krowka MJ, Brown RS, Reinen J, Stadheim L, Faulk D, Nielsen C, Al-Naamani N, Roberts K, Zacks S, Perry T, Trotter J, Kawut SM. Risk Factors and Impact of Chronic Obstructive Pulmonary Disease in Candidates for Liver Transplantation. Liver Transpl (in press)
  • Dove LM, Rosen RC, Ramcharran D, Wahed AS, Belle SH, Brown RS, Hoofnagle JH for the Virahep-C Study Group. Decline in Male Sexual Desire, Function and Satisfaction During and After Antiviral Therapy for Chronic Hepatitis C.
  • Stein EM, Cohen A, Freeby M, Rogers H, Kokolus S, Scott V, Mancini D, Restaino S, Brown R, McMahon DJ, Shane E. Severe Vitamin D Deficiency among Heart and Liver Transplant Recipients. Clin Transplant 2009 DOI: 10.1111/J.1399-0012
  • Verna EC, DeMartin E, Burra P, Neri D, Gaglio PJ, Emond JC, Brown RS Jr. The Impact of Hepatitis C and Biliary Complications on Patient and Graft Survival Following Liver Transplantation. Am Jour of Transpl 2009, 9:1398-1405
  • Roberts KE, Fallon MB, Krowka MJ, Brown RS Jr., Trotter JF, Tighiouart H, Knowles JA, Babinowitz D, Benza RL, Badesch DB, Taichman DB, Horn EM, Zacks S, Kaplowitz N, Kawut SM for the PVCLD Study Group. Genetic Risk Factors for Portopulmonary Hypertension in Patients with Advanced Liver Disease. 2009 AmJ Resp Crit Care Med Vol 179 pp835-842.
  • Lai, JC, Pichardo, EM, Emond JC, Brown RS Jr. Resource Utilization of Living Donor Versus Deceased Donor Liver Transplantation is Similar at an Experienced Transplant Center. Am Jour of Trans 2009; 9: 586-591
  • Lai JC, Lebwohl B, Montero A, Brown RS Jr*. The Specialized Housestaff Service Model: A Novel Housestaff Educational Model for Quaternary-Care Patients at an Academic Medical Center. Academic Medicine February 2009 Vol 84;2:206-11
  • Rana A, Hardy MA, Halazun KJ, Woodland DC, Ratner LE, Samstein B, Guarrera JV, Brown RS Jr, Emond JC. Survival Outcomes Following Liver Transplantation (SOFT) score: A novel method to predict patient survival following liver transplantation. Am J Transplant 2008;8:2537-46.
  • Siegel, AB, Cohen E, Ocean A, Lehrer D, Goldenberg A, Knox JJ, Chen H, Garvey SC, Weinberg A, Mandeli J, Christos P, Mazumdar M, Brown RS Jr., Popa E, Jin D, Rafii S, Schwartz J. A Phase II Trial Evaluating the Clinical and Biological Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma. J Clin Oncol 2008;26:2992-8.
  • Kawut SM, Krowka MJ, Trotter JF, Roberts KE, Benza RL, Badesch DB, Taichman DB, Horn EM, Zacks S, Kaplowitz N, Brown RS, Fall MB. Clinical Risk Factors for Portopulmonary Hypertension. Hepatology 2008;48:196-203.
  • Siegel AB, McBride R, El-Serag H, Zablotska L, Hershman D, Brown RS Jr., Neugut AI. The Risk of hepatocellular Carcinoma in Patients with Previous Malignancy. Presented, GI ASCO 2007. Cancer Invest 2008;26:511-5.
  • Brown RS Jr* Live Donors in Liver Transplantation. Gastroenterology 2008;134:1802-1813
  • Fallon MB, Krowka MJ, Brown RS, Trotter JF, Zacks S, Roberts KE, Shah VH, Kaplowitz N, Forman L, Wille K, Kawut SM for the PVCLD Study Group. Impact of Hepatopulmonary Syndrome on Quality of Life and Survival in Liver Transplant Candidates. Gastroenterology 2008;135:1168-75.
  • Siegel AB, McBride RB, El-Serag HB, Hershman DL, Brown RS, Jr., Renz JF, Emond JC, Neugut AI. Racial Disparities in Utilization of Liver Transplantation for Hepatocellular Carcinoma in the United States 1998-2002. Am J Gastroenterol 2008;103:120-7
  • Haskal ZJ, Brown RS Jr.* Role of Biliary Stress Manometry after Biliary Stricture Dilation in Living Donor Liver Transplant Recipients. J Vasc Interv Radiol 2008; 19:216-219
  • Afdhal N, McHutchinson J, Brown R, Jacobson I, Manns M, Poordad F, Weksler B, Esteban R. Thrombocytopenia Associated with Chronic Liver Disease. J Hepatol 2008;48:1000-07
  • Hassanein TI, Tofteng F, Brown RS Jr, McGuire B, Lynch P, Mehta R, Larsen FS, Gorbein J, Stange J, Blei AT. Randomized Controlled Study of Extracorporeal Albumin Dialysis for Hepatic Encepholopathy in Advanced Cirrhosis. Hepatology 2007;46:1853-62
  • Jakab SS, West AB, Meighan DM, Brown RS Jr, Hale WB. Mycophenolate mofetil for drug-induced vanishing bile duct syndrome. World J Gastroenterol. 2007 Dec 7; 13(45):6087-6089.
  • Brown RS Jr. Steroids in recurrent hepatitis C following liver transplantation: Pitfall or panacea? J Hepatol. 2007 Dec; 47(6):741-3. Epub 2007 Oct 8.
  • Weisberg IS, Brown RS Jr, Sigal SH. Hepatitis B and end-stage liver disease. Clin Liver Dis. 2007 Nov; 11(4):893-916.
  • Hassanein TI, Tofteng F, Brown RS Jr, McGuire B, Lynch P, Mehta R, Larsen FS, Gornbein J, Stange J, Blei AT. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology. 2007 Nov 1.
  • Jacobson IM, Brown RS Jr, McCone J, Black M, Albert C, Dragutsky MS, Siddiqui FA, Hargrave T, Kwo PY, Lambiase L, Galler GW, Araya V, Freilich B, Harvey J, Griffel LH, Brass CA; WIN-R Study Group. Impact of weight-based ribavirin with peginterferon alfa-2b in African Americans with hepatitis C virus genotype 1. Hepatology. 2007 Oct; 46(4):982-90.
  • Jacobson IM, Brown RS Jr, Freilich B, Afdhal N, Kwo PY, Santoro J, Becker S, Wakil AE, Pound D, Godofsky E, Strauss R, Bernstein D, Flamm S, Pauly MP, Mukhopadhyay P, Griffel LH, Brass CA; WIN-R Study Group. Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: a randomized trial. Hepatology. 2007 Oct; 46(4):971-81.
  • Guarrera JV, Alkofer BJ, Feirt N, Sandoval R, Samstein B, Smith ET Jr, Marshman D, Cogswell C, Vannatta J, Brown RS Jr, Emond JC, Renz JF. Discovery of diffuse biliary microhamartomas during liver procurement. Liver Transpl. 2007 Oct; 13(10):1470-1.
  • Siegel AB, McBride R, El-Serag H, Hershman D, Brown RS Jr, Renz J, Neugut A. Racial disparities in utilization of liver transplantation for hepatocellular carcinoma. Presentation, GI ASCO 2006, accepted, A J Gastroenterol.
  • Hernandez L, Johnson TC, Naiyer AJ, Kryszak D, Ciaccio EJ, Min A, Bodenheimer HC Jr, Brown RS Jr, Fasano A, Green PH. Chronic Hepatitis C Virus and Celiac Disease, is there an Association? Dig Dis Sci. 2007 Jun 5.
  • Fisher RA, Kulik LM, Freise CE, Lok AS, Shearon TH, Brown RS Jr, Ghobrial RM, Fair JH, Olthoff KM, Kam I, Berg CL; A2ALL Study Group. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant. 2007 Jun; 7(6):1601-8.
  • McHutchison JG, Manns MP, Brown RS Jr, Reddy KR, Shiffman ML, Wong JB. Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy. Am J Gastroenterol. 2007 Apr; 102(4):880-9.
  • Terrault NA, Shiffman ML, Lok AS, Saab S, Tong L, Brown RS Jr, Everson GT, Reddy KR, Fair JH, Kulik LM, Pruett TL, Seeff LB; A2ALL Study Group. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl. 2007 Jan; 13(1):122-9.
  • Brown RS Jr. Customizing treatment to patient populations. Nat Clin Pract Gastroenterol Hepatol. 2007 Jan; 4 Suppl 1:S3-9.
  • Olsen SK, Brown RS Jr. Hepatitis B treatment: Lessons for the nephrologist. Kidney Int. 2006 Dec;70(11):1897-904. Epub 2006 Oct 4.
  • Verna EC, Brown RS Jr. Hepatitis C virus and liver transplantation. Clin Liver Dis. 2006 Nov; 10(4):919-40.
  • Lefkowitch JH, Lobritto SJ, Brown RS Jr, Emond JC, Schilsky ML, Rosenthal LA, George DM, Cairo MS. Ground-glass, polyglucosan-like hepatocellular inclusions: A "new" diagnostic entity. Gastroenterology. 2006 Sep; 131(3):713-8.
  • Brown RS Jr. Asymptomatic liver mass. Gastroenterology. 2006 Aug; 131(2):619-23.
  • Brown RS Jr. Evaluating the evidence from clinical trials in chronic hepatitis C. J Viral Hepat. 2006 May; 13 Suppl 1:15-25.
  • Gaglio PJ, Brown RS Jr. Who should treat liver transplant patients? The transplant hepatologist or the gastroenterologist? Part I: the transplant hepatologist. J Hepatol. 2006 Apr; 44(4):655-7.
  • Dickson RC, Terrault NA, Ishitani M, Reddy KR, Sheiner P, Luketic V, Soldevila-Pico C, Fried M, Jensen D, Brown RS Jr, Horwith G, Brundage R, Lok A. Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease. Liver Transpl. 2006 Jan; 12(1):124-33.
  • Moss J, Lapointe-Rudow D, Renz JF, Kinkhabwala M, Dove LM, Gaglio PJ, Emond JC, Brown RS Jr. Select utilization of obese donors in living donor liver transplantation: implications for the donor pool. Am J Transplant. 2005 Dec; 5(12):2974-81.
  • Jacobson IM, Gonzalez SA, Ahmed F, Lebovics E, Min AD, Bodenheimer HC Jr, Esposito SP, Brown RS Jr, Bräu N, Klion FM, Tobias H, Bini EJ, Brodsky N, Cerulli MA, Aytaman A, Gardner PW, Geders JM, Spivack JE, Rahmin MG, Berman DH, Ehrlich J, Russo MW, Chait M, Rovner D, Edlin BR. A randomized trial of pegylated interferon alpha-2b plus ribavirin in the retreatment of chronic hepatitis C. Am J Gastroenterol. 2005 Nov; 100(11):2453-62.
  • Verna EC, Hunt KH, Renz JF, Rudow DL, Hafliger S, Dove LM, Kinkhabwala M, Emond JC, Brown RS Jr. Predictors of candidate maturation among potential living donors. Am J Transplant. 2005 Oct; 5(10):2549-54.
  • Rudow DL, Brown RS Jr. Role of the independent donor advocacy team in ethical decision making. Prog Transplant. 2005 Sept; 15(3):298-302.
  • Brown RS Jr. MARS preconditioning for living donor liver transplantation: panacea or placebo? Liver Int. 2005 Aug; 25(4):692-5.
  • Rudow DL, Chariton M, Sanchez C, Chang S, Serur D, Brown RS Jr. Kidney and liver living donors: a comparison of experiences. Prog Transplant. 2005 Jun; 15(2):185-91.
  • Herrine SK, Brown RS Jr, Bernstein DE, Ondovik MS, Lentz E, Te H. Peginterferon alpha-2a combination therapies in chronic hepatitis C patients who relapsed after or had a viral breakthrough on therapy with standard interferon alpha-2b plus ribavirin: a pilot study of efficacy and safety. Dig Dis Sci. 2005 Apr; 50(4):719-26.
  • Sterling RK, Brown RS Jr, Hofmann CM, Luketic VA, Stravitz RT, Sanyal AJ, Contos MJ, Mills AS, Smith V, Shiffman ML. The Spectrum of Chronic Hepatitis C Virus Infection in the Virginia Correctional System: Development of a Strategy for the Evaluation and Treatment of Inmates with HCV. Am J Gastroenterol. 2005 Feb; 100(2):313-21.

Books

  • rown Jr., Robert S., Guest Editor, Gastrointestinal Endoscopy – Clinics of North America, W.B. Saunders, Volume II, Number 1, January 2000.

Case Reports

  • Yee HF Jr, Brown RS Jr, Ostroff JW. Fatal Clostridium difficile enteritis following total abdominal colectomy. J Clin Gastro 1995; 22: 45-7.
  • Brown RS Jr, Farraye F, Peppercorn MA, Glotzer DG, Antonioli D, Taylor G. Carcinoid tumor of the esophagus. J Clin Gastro 1994; 19: 338-9.
Locations

1305 York Avenue Office

1305 York Avenue
New York, NY 10021

Phone: (646) 962-5483

Fax: (646) 962-0110

Get Directions


Professor of Pediatrics (in Surgery) at CUMC

Frank Cardile Professor of Medicine

Professor of Medicine At Weill Cornell Medical College, Cornell Univ

  • Senior Attending Teaching Award, 2009, Awarded by NewYork-Presbyterian Hospital/Columbia University Medical Center Department of Medicine Housestaff Office
  • Young Investigator Award, American Society of Transplant Physicians, 1996